Morgan Stanley cuts Enphase target to $16
The large target gap and post-signal decline reinforce a bearish read, though this remains an analyst opinion rather than a company catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The large target gap and post-signal decline reinforce a bearish read, though this remains an analyst opinion rather than a company catalyst.
What happened, with direct paths to the underlying reporting
Morgan Stanley lowered its ENPH price target to $16; the posted price was $29.76. The target is about 46% below that price, a clearly bearish analyst view.
Target: $16
Posted price: $29.76
Analyst firm: Morgan Stanley
Analyst: Andrew Percoco
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.